Sorrento Therapeutics, Inc.
SRNE
Price:
$0.0095
Market Cap:
$5.24M
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti...[Read more]
Industry
Biotechnology
IPO Date
2007-01-19
Stock Exchange
NASDAQ
Ticker
SRNE
The PE Ratio as of July 2024 (TTM) for Sorrento Therapeutics, Inc. (SRNE) is -0.01
According to Sorrento Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.73% compared to the average of -0.79 of the last 4 quarters.
Sorrento Therapeutics, Inc. (SRNE) Historical PE Ratio (quarterly & annually)
How has SRNE PE Ratio performed in the past?
The mean historical PE Ratio of Sorrento Therapeutics, Inc. over the last ten years is -0.69. The current -0.01 PE Ratio has changed 45.40% with respect to the historical average. Over the past ten years (40 quarters), SRNE's PE Ratio was at its highest in in the March 2021 quarter at 231.13. The PE Ratio was at its lowest in in the September 2015 quarter at -83.38.
Average
-0.69
Median
-3.62
Minimum
-7.75
Maximum
29.02
Sorrento Therapeutics, Inc. (SRNE) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Sorrento Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 284.35%
Maximum Annual PE Ratio = 29.02
Minimum Annual Increase = -816.49%
Minimum Annual PE Ratio = -7.75
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.66 | -79.21% |
| 2021 | -3.20 | -37.15% |
| 2020 | -5.08 | 284.35% |
| 2019 | -1.32 | 5.67% |
| 2018 | -1.25 | -104.31% |
| 2017 | 29.02 | -816.49% |
| 2016 | -4.05 | -42.28% |
| 2015 | -7.02 | -9.47% |
| 2014 | -7.75 | 39.37% |
| 2013 | -5.56 | -72.59% |
Sorrento Therapeutics, Inc. (SRNE) Average PE Ratio
How has SRNE PE Ratio performed in the past?
The current PE Ratio of Sorrento Therapeutics, Inc. (SRNE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.98
5-year avg
-2.30
10-year avg
-0.69
Sorrento Therapeutics, Inc. (SRNE) PE Ratio vs. Peers
How is SRNE’s PE Ratio compared to its peers?
Sorrento Therapeutics, Inc.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
Build a custom stock screener for Sorrento Therapeutics, Inc. (SRNE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sorrento Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sorrento Therapeutics, Inc. (SRNE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sorrento Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Sorrento Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Sorrento Therapeutics, Inc. (SRNE)?
What is the highest PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?
What is the 3-year average PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?
What is the 5-year average PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?
How does the current PE Ratio for Sorrento Therapeutics, Inc. (SRNE) compare to its historical average?